Research Article

PLASMA OXYTOCIN IMMUNOREACTIVE PRODUCTS AND RESPONSE TO TRUST IN PATIENTS WITH SOCIAL ANXIETY DISORDER

  1. Elizabeth A. Hoge M.D., M.M.Sc.1,*,
  2. Elizabeth A. Lawson M.D., M.M.Sc.2,
  3. Christina A. Metcalf B.A.1,
  4. Aparna Keshaviah Sc.M.1,
  5. Paul J. Zak Ph.D.3,
  6. Mark H. Pollack M.D.4,
  7. Naomi M. Simon M.D.1

Article first published online: 17 JUL 2012

DOI: 10.1002/da.21973

Issue

Depression and Anxiety

Depression and Anxiety

Volume 29, Issue 11, pages 924–930, November 2012

Additional Information

How to Cite

Hoge, E. A., Lawson, E. A., Metcalf, C. A., Keshaviah, A., Zak, P. J., Pollack, M. H. and Simon, N. M. (2012), PLASMA OXYTOCIN IMMUNOREACTIVE PRODUCTS AND RESPONSE TO TRUST IN PATIENTS WITH SOCIAL ANXIETY DISORDER. Depress. Anxiety, 29: 924–930. doi: 10.1002/da.21973

Author Information

  1. 1

    Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

  2. 2

    Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

  3. 3

    Center for Neuroeconomics Studies, Claremont Graduate University, Claremont, California

  4. 4

    Department of Psychiatry, Rush University Medical Center, Chicago, Illinois

*Correspondence to: Elizabeth Hoge, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Square, 6th Floor, Boston, MA 02114. E-mail: ehoge@partners.org

  1. Conflicts of Interest (government sources not included):

  2. Paul Zak, PhD: John Templeton Foundation, BrightSight Speakers Bureau.

  3. Mark Pollack, MD: Grant Funding: Bristol Myers Squibb, Euthymics, Forest Laboratories, GlaxoSmithKline, Eli Lilly, Sepracor. Consulting/honorarium: Brain Cells, Eli Lilly, Johnson and Johnson, Medavante, Labopharm, Mindsite, Otsuka, Sepracor, Targia Pharmaceuticals, Pfizer. CME supported activities: Astra-Zeneca, Sepracor, Pfizer. Equity: Medavante, Mensante Corporation, Mindsite, Targia Pharmaceuticals. Royalty/patent: SIGH-A, SAFER interviews

  4. Naomi Simon, MD: Grants: American Foundation for Suicide Prevention, Forest Laboratories, NARSAD, Glaxo SmithKline, Lilly, Pfizer, Sepracor. Payment for lectures: Pfizer

Publication History

  1. Issue published online: 5 NOV 2012
  2. Article first published online: 17 JUL 2012
  3. Manuscript Accepted: 2 JUN 2012
  4. Manuscript Revised: 11 MAY 2012
  5. Manuscript Received: 25 FEB 2012

Funded by

  • NIH. Grant Number: UL1 RR 025758
  • Harvard University and its affiliated academic health care centers

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (491K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Get PDF (491K)